0
Is breast cancer HER2-positive curable?
- 1 people answered
1 Vote
1 Contributor
2376 Views 
0 Saved
1 Vote 1 Contributor2376 Views 0 SavedYou might also be interested in
A new treatment for breast cancer has completely eradicated tumours in just 11 days. A team of researchers in the UK claims the new two-pronged technique could spare thousands of women from gruelling chemotherapy. Doctors combined two existing cancer drugs - Tyverb and Herceptin – and gave them t....
In general, yes it is safe. But there are exceptions based on the conditions. A woman who is developing breast cancer might be excreting small amounts of fluids from the nipples. A woman who is lactating (to feed babies) is also ‘leaking’ fluids. Now, whenever a fluid is exchanged between two bod....
Kanishka Pandey
HER2 is a gene that creates HER2 proteins or receptors. These receptors help control growth and repair of breast cells. An overexpression of HER2 protein causes out-of-control reproduction of breast cells.
HER2-positive breast cancers are known to be more aggressive than HER2-negative breast cancers and are more likely to recur than HER2-negative breast cancer. The recurrence usually takes place within five years of treatment.
The good news is that recurrence is less likely these days than ever before. This is largely due to the latest targeted treatments. In fact, most people treated for early stage HER2-positive breast cancer don’t relapse. If your breast cancer is HR-positive, hormonal therapy may help reduce the risk of recurrence.
Your treatment plan will probably include a combination of therapies such as:
Targeted treatments (medicines like Herceptin, Kadcyla, Perjeta and Tykerb are used in this process) Once the treatment ends, you’ll still need periodic testing for signs of recurrence.